These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6977047)
1. [Effect of methotrexate-citrovorum factor (MTX-CF) rescue therapy in a case of malignant histiocytosis with disseminated intravascular coagulation (author's transl)]. Fukuhara S; Kim R; Aoki Y; Okada S; Yoneda M; Kita K; Nasu K; Tatsumi E; Shirakawa S; Uchino H Rinsho Ketsueki; 1981 Jul; 22(7):1145-51. PubMed ID: 6977047 [No Abstract] [Full Text] [Related]
2. [Disturbances of coagulation following high-dosage methotrexate with citrovorum factor rescue in patients with osteogenous sarcoma. (author's transl)]. Göbel U; Jürgens H; von Voss H; Wahn V; Rosen G Klin Padiatr; 1981 Mar; 193(2):94-8. PubMed ID: 6971958 [No Abstract] [Full Text] [Related]
3. [Studies on the effect of high-dose methotrexate-citrovorum factor treatment for 89Sr induced osteosarcoma in mice (author's transl)]. Nakamura T Nihon Seikeigeka Gakkai Zasshi; 1982 Feb; 56(2):149-61. PubMed ID: 6978919 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of malignant neoplasms in advanced stages with HDMTX-CF Rescue (high-dose methotrexate-citrovorum factor rescue)]. Paparopoli G; Agostara B; Di Girolamo G Clin Ter; 1981 May; 97(3):271-81. PubMed ID: 6974631 [No Abstract] [Full Text] [Related]
5. [Effects of a massive dosage of methotrexate and leucovorin rescue therapy on acute leukemia and malignant lymphoma]. Gan To Kagaku Ryoho; 1982 Mar; 9(3):421-32. PubMed ID: 6764106 [TBL] [Abstract][Full Text] [Related]
6. [High-dose methotrexate with citrovorum factor rescue in the treatment of malignant tumors (author's transl)]. Wang QL; Sun Y; Zhou JC; Song SZ; Lu L; Ye ZS Zhonghua Zhong Liu Za Zhi; 1979; 1(2):144-9. PubMed ID: 317948 [No Abstract] [Full Text] [Related]
7. [Massive dose methotrexate with citrovorum factor rescue: MTX-pharmacokinetics, excretion pattern, and techniques for safety administration (author's transl)]. Sasaki K; Fujimoto T Nihon Gan Chiryo Gakkai Shi; 1979 Oct; 14(6):988-96. PubMed ID: 317293 [No Abstract] [Full Text] [Related]
8. Comparative effects of citrovorum factor and carboxypeptidase G1 on cerebrospinal fluid-methotrexate pharmacokinetics. Abelson HT; Ensminger W; Rosowsky A; Uren J Cancer Treat Rep; 1978 Oct; 62(10):1549-52. PubMed ID: 309355 [TBL] [Abstract][Full Text] [Related]
10. Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration. Von Hoff DD; Penta JS; Helman LJ; Slavik M Cancer Treat Rep; 1977 Jul; 61(4):745-8. PubMed ID: 301783 [TBL] [Abstract][Full Text] [Related]
11. [High-dose methotrexate with citrovorum factor rescue in osteogenic carcinoma]. Levi M; Sulkes A; Katz E; Rizel S; Biran S Harefuah; 1980 Sep; 99(5-6):110-3. PubMed ID: 6970707 [No Abstract] [Full Text] [Related]
12. [Weekly high-dose methotrexate with citrovorum factor rescue for non-Hodgkin's lymphoma--serum methotrexate level and safety administration (author's transl)]. Sasaki K; Fujimoto T; Goya N Rinsho Ketsueki; 1979 Jan; 20(1):90-7. PubMed ID: 311390 [No Abstract] [Full Text] [Related]
13. [Blastic crisis of a chronic myelogenous leukemia with disseminated intravascular coagulation, with special reference to "AAAP" therapy (author's transl)]. Yoshikawa H; Maruo K Rinsho Ketsueki; 1980 Jan; 21(1):52-8. PubMed ID: 6929365 [No Abstract] [Full Text] [Related]
14. [Phase II trial of high dose methotrexate with citrovorum factor "rescue" for hematological malignancies]. Ueda T; Kubota Y; Saigo K; Tanaka T; Takubo T; Shibata H; Nakamura H; Masaoka T; Yoshitake J; Ishigami S Rinsho Ketsueki; 1982 Jun; 23(6):854-61. PubMed ID: 6983592 [No Abstract] [Full Text] [Related]
15. [Determination of MTX plasma concentration in cancer patients following administration of HD-MTX-CFR (author's transl)]. Wang YX; Zhang QF; Zhang NF; Zhang XL; Kang SH Yao Xue Xue Bao; 1981 Nov; 16(11):815-20. PubMed ID: 6979162 [No Abstract] [Full Text] [Related]
16. New "rescue" with massive doses of citrovorum factor for potentially lethal methotrexate toxicity. Djerassi I; Kim JS; Nayak N; Ohanissian H; Adler S; Hsieh S Cancer Treat Rep; 1977 Jul; 61(4):749-50. PubMed ID: 301784 [No Abstract] [Full Text] [Related]
17. [High dose methotrexate with citrovorum factor rescue therapy. (2) Measurement of methotrexate and its major metabolite, 7-hydroxymethotrexate in cerebrospinal fluid by high pressure liquid chromatography]. Tanaka J; Kinpara H; Sasaki K; Fujimoto T Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):889-95. PubMed ID: 6604768 [No Abstract] [Full Text] [Related]
18. [High dose methotrexate with leucovorin rescue in the treatment of malignant lymphoma]. Sampi K; Hattori M Gan To Kagaku Ryoho; 1982 Jul; 9(6):1068-73. PubMed ID: 6985194 [TBL] [Abstract][Full Text] [Related]
19. [A case of leukemic reticulosis, myelogenous type with consumption coagulopathy and mediastinal tumor involving the thymus (author's transl)]. Yoshikawa H; Takeyama H; Nishiwaki H; Kamiya T; Yamada K Rinsho Ketsueki; 1976 May; 17(5):553-61. PubMed ID: 985902 [No Abstract] [Full Text] [Related]
20. [An autopsy case of myelogenous malignant reticulosis associated with neurologic symptoms and disseminated intravascular coagulation (author's transl)]. Nakao J; Ogawa M; Shirakura T; Tomonaga M; Inoue T; Tanaka K; Matsuda T Rinsho Ketsueki; 1977 Nov; 18(11):1355-62. PubMed ID: 599665 [No Abstract] [Full Text] [Related] [Next] [New Search]